RxDoctor Payments DataLook up a doctor →

Darshan Godkar, MD

Interventional Cardiology · Cedar Knolls, NJNPI 1952515264

Payments from drug & device makers

$260,468in general payments, 2019–2025

Across 894 payments — averaging $291.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$106K
  • Boehringer Ingelheim$60K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$21K
  • Johnson & Johnson$19K
  • Boston Scientific$18K
  • Lilly USA, LLC$10K
  • plus $27K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)142$106,458
Boehringer Ingelheim96$59,838
Boehringer Ingelheim Pharma GmbH & Co.kg2$20,840
Johnson & Johnson56$18,874
Boston Scientific65$17,580
Lilly USA, LLC11$9,976
Medtronic(2 entities)84$7,357
Cvrx, Inc.10$4,502
Boehringer Ingelheim International GmbH19$3,963
Abbott35$2,901
Edwards Lifesciences12$1,454
Novartis79$863
Penumbra, Inc.3$794
Shockwave Medical, Inc5$593
Merck38$582
AstraZeneca30$441
Novo Nordisk21$433
E.r. Squibb & Sons, L.L.C.34$356
Sanofi-aventis U.S. LLC18$264
Arbor Pharmaceuticals, Inc.13$245
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)10$206
Esperion Therapeutics, Inc.12$171
Lexicon Pharmaceuticals, Inc.6$131
Amarin Pharma, Inc.9$124
Cardiovascular Systems Inc.2$114
Atricure, Inc.2$106
Pfizer7$106
Philips North America LLC4$104
Alnylam Pharmaceuticals Inc.6$103
Bardy Diagnostics, Inc.8$94
Regeneron Healthcare Solutions, Inc.6$94
Lundbeck LLC7$93
Kowa Pharmaceuticals America, Inc.5$67
Kiniksa Pharmaceuticals International, PLC4$59
Scpharmaceuticals Inc.3$52
Kestra Medical Technology Services, Inc.3$48
Kiniksa Pharmaceuticals, Ltd.3$44
GSK3$43
Altathera Pharmaceuticals LLC2$37
United Therapeutics Corporation2$35
Althera Pharmaceuticals LLC2$34
Acist Medical Systems, Inc.1$30
Impulse Dynamics (USA) Inc.1$30
Baxter Healthcare1$27
Biosense Webster, Inc.1$27
Tactile Systems Technology Inc1$24
Heartflow, Inc.1$22
Ionis Pharmaceuticals, Inc.1$19
Abiomed1$17
Azurity Pharmaceuticals, Inc.1$17
Corcept Therapeutics1$16
Itamar Medical Inc1$16
Hikma Pharmaceuticals USA1$15
Amryt Pharma Holdings Ltd1$14
Acarix USA Inc.1$10
Bard Peripheral Vascular, Inc.1$4

How this compares

$260,468 in reported general payments places this provider in the 90th percentile of 166 interventional cardiology providers in New Jersey.

See all interventional cardiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$1,713,356
Medicare patients
1,263
Services billed
19,346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Cedar Knolls

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →